AOSD

Clinical trials for AOSD explained in plain language.

Never miss a new study

Get alerted when new AOSD trials appear

Sign up with your email to follow new studies for AOSD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug aims to calm dangerous immune storms in Still's and lupus patients

Disease control Completed

This study tested a drug called emapalumab in 33 children and adults with macrophage activation syndrome (MAS), a life-threatening immune overreaction, linked to Still's disease or lupus. The goal was to see if the drug could safely control the condition and reduce the need for h…

Matched conditions: AOSD

Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control

Last updated Jun 27, 2026 09:05 UTC

AOSD

Get alerted when new AOSD trials appear

New drug aims to calm dangerous immune storms in Still's and lupus patients